Infant Mesenchymal Stem Cell Insulin Action Is Associated With Maternal Plasma Free Fatty Acids, Independent of

Alec B Chaves1,2, Donghai Zheng1,2, Jonathan A Johnson1,2

  • 1Human Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, NC.

Diabetes
|May 27, 2022
PubMed

Insights

Maternal obesity during pregnancy may not directly impact infant insulin action, but higher maternal lipids and cord leptin levels are linked to increased insulin sensitivity in newborns. This suggests altered growth and lipid storage pathways.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Developmental Biology

Background:

  • Maternal obesity is linked to offspring insulin resistance in animal models.
  • Translating these findings to human intrauterine effects remains unclear.

Purpose of the Study:

  • To investigate the impact of the intrauterine environment on infant insulin action in humans.
  • To explore the relationship between maternal metabolic factors and infant mesenchymal stem cell (MSC) insulin sensitivity.

Main Methods:

  • Isolated MSCs from umbilical cord tissue of infants born to mothers with normal weight or obesity.
  • Assessed insulin-stimulated glycogen storage in MSCs during in vitro myogenesis.
  • Measured maternal free fatty acid (FFA) concentration, cord leptin, and intracellular triglyceride content.

Main Results:

  • No significant difference in insulin action was observed based solely on maternal obesity status.
  • Maternal FFA concentration, cord leptin, and intracellular triglyceride content positively correlated with insulin action.
  • MSCs from infants of mothers with elevated FFAs showed increased mTOR signaling pathway activation.

Conclusions:

  • Elevated maternal lipid availability, not maternal obesity per se, is associated with enhanced insulin action in infant MSCs.
  • These findings suggest potential upregulation of growth and lipid storage pathways in infants exposed to maternal overnutrition.